Is prevention of sterility possible in men?RADFORD, John A.Annals of oncology. 2000, Vol 11, pp 173-174, issn 0923-7534, SUP3Conference Paper

Myocardial infarction mortality risk after treatment for hodgkin disease : A collaborative british cohort studySWERDLOW, Anthony J; HIGGINS, Craig D; LINCH, David C et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 3, pp 206-214, issn 0027-8874, 9 p.Article

Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantationBROOK, Philip F; RADFORD, John A; SHALET, Steven M et al.Fertility and sterility. 2001, Vol 75, Num 2, pp 269-274, issn 0015-0282Article

Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma : A european organisation for research and treatment of cancer soft tissue and bone sarcoma group studyLORIGAN, Paul; VERWEIJ, Jaap; BLAY, Jean-Yves et al.Journal of clinical oncology. 2007, Vol 25, Num 21, pp 3144-3150, issn 0732-183X, 7 p.Article

Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma : Results of the United Kingdom lymphoma group LY09 trial (ISRCTN97144519)JOHNSON, Peter W. M; RADFORD, John A; RYDER, David et al.Journal of clinical oncology. 2005, Vol 23, Num 36, pp 9208-9218, issn 0732-183X, 11 p.Article

Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 TrialPETTITT, Andrew R; JACKSON, Richard; CATOVSKY, Daniel et al.Journal of clinical oncology. 2012, Vol 30, Num 14, pp 1647-1655, issn 0732-183X, 9 p.Article

YY1 expression predicts favourable outcome in follicular lymphomaNAIDOO, Khimara; CLAY, Vanessa; HOYLAND, Judith A et al.Journal of clinical pathology. 2011, Vol 64, Num 2, pp 125-129, issn 0021-9746, 5 p.Article

Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. CommentaryDAVE, Sandeep S; BYERS, Richard J; SAKHINIA, Ebrahim et al.Blood. 2008, Vol 111, Num 9, issn 0006-4971, 4427-4428, 4764-4770 [9 p.]Article

Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort StudySWERDLOW, Anthony J; HIGGINS, Craig D; LINCH, David C et al.Journal of clinical oncology. 2011, Vol 29, Num 31, pp 4096-4104, issn 0732-183X, 9 p.Article

Methods comparison for high-resolution transcriptional analysis of archival material on Affymetrix Plus 2.0 and Exon 1.0 microarraysLINTON, Kim M; HEY, Yvonne; DIBBEN, Sian et al.BioTechniques. 2009, Vol 47, Num 1, issn 0736-6205, 587-596 [6 p.]Article

Killing of non-hodgkin lymphoma cells by autologous CD19 engineered T cellsCHEADLE, Eleanor J; GILHAM, David E; THISTLETHWAITE, Fiona C et al.British journal of haematology. 2005, Vol 129, Num 3, pp 322-332, issn 0007-1048, 11 p.Article

MALT lymphoma with t(14;18)(q32;q21)/IGH-MALTI is characterized by strong cytoplasmic MALTI and BCL10 expressionHONGTAO YE; LIPING GONG; MARTIN-SUBERO, Jose I et al.Journal of pathology. 2005, Vol 205, Num 3, pp 293-301, issn 0022-3417, 9 p.Article

Consolidation Radiotherapy in Patients With Advanced Hodgkin's Lymphoma: Survival Data From the UKLG LY09 Randomized Controlled Trial (ISRCTN97144519)JOHNSON, Peter W. M; SYDES, Matthew R; HANCOCK, Barry W et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3352-3359, issn 0732-183X, 8 p.Article

Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling. CommentaryROSENBERG, Philip S; SAKHINIA, Ebrahim; GLENNIE, Caroline et al.Blood. 2007, Vol 109, Num 9, issn 0006-4971, 3621,3922-3928 [8 p.]Article

Phase I evaluation of a fully human anti -α_v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumorsMULLAMITHA, Saifee A; TON, Nhuan C; HOPE, Lynn et al.Clinical cancer research. 2007, Vol 13, Num 7, pp 2128-2135, issn 1078-0432, 8 p.Article

The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centreHOWELL, Sacha J; GREY, Mark; CHANG, James et al.British journal of haematology. 2002, Vol 119, Num 2, pp 408-411, issn 0007-1048, 4 p.Article

Fractionated ⁹⁰Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI CriteriaILLIDGE, Tim M; MAYES, Sam; ZIVANOVIC, Maureen et al.Journal of clinical oncology. 2014, Vol 32, Num 3, pp 212-218, issn 0732-183X, 7 p.Article

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cyclesCUNNINGHAM, David; HAWKES, Eliza A; DAVIES, John et al.Lancet (British edition). 2013, Vol 381, Num 9880, pp 1817-1826, issn 0140-6736, 10 p.Article

Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort StudySWERDLOW, Anthony J; COOKE, Rosie; LINCH, David C et al.Journal of clinical oncology. 2012, Vol 30, Num 22, pp 2745-2752, issn 0732-183X, 8 p.Article

Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differencesEVE, Heather E; CAREY, Sean; RICHARDSON, Sarah J et al.British journal of haematology. 2012, Vol 159, Num 2, pp 154-163, issn 0007-1048, 10 p.Article

A prospective clinicopathologic study of dose-modified CODOX-M/TVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)MEAD, Graham M; BARRANS, Sharon L; WENDI QIAN et al.Blood. 2008, Vol 112, Num 6, pp 2248-2260, issn 0006-4971, 13 p.Article

Bortezomib therapy in patients with relapsed or refractory lymphoma : Potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activitySTRAUSS, Sandra J; MAHARAJ, Lenushka; SCHENKEIN, David et al.Journal of clinical oncology. 2006, Vol 24, Num 13, pp 2105-2112, issn 0732-183X, 8 p.Article

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I¹³¹ tositumomabBENNETT, John M; KAMINSKI, Mark S; CAPIZZI, Robert L et al.Blood. 2005, Vol 105, Num 12, pp 4576-4582, issn 0006-4971, 7 p.Article

Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomabKAMINSKI, Mark S; RADFORD, John A; GREGORY, Stephanie A et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7985-7993, issn 0732-183X, 9 p.Article